iHuman Inc. IH
Set alert
As of Oct 30, 10:14 AM ET
- YTD
- -43.81%
- 1 year
- -55.81%
- Open
- 1.18
- Prev close
- 1.18
- Mkt cap
- 60.32M
- Vol
- 477
- Avg vol
- 6.45K
- EPS
- 0.06
- P/E
- 19.67
- Div yield
- 0.00%
More statistics
- Low
- 1.18
- High
- 1.18
- Forward P/E
- 9.16
- Beta
- 0.47
- Short ratio
- 0.15
- Inst. own
- 0.62%
- Dividend
- 0.00
- Ex-div date
- Mar 26, 2024
- 50-d avg
- 1.74
- 200-d avg
- 1.77
- 1y target
- 0.00
News
2 weeks ago gurufocus.com
Takeda's ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1
Takeda ([url="]TSE:4502/NYSE: TAK[/url])announced today that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (N
3 weeks ago gurufocus.com
Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference
[url="]Vertex Pharmaceuticals Incorporated[/url] (Nasdaq: VRTX) today announced new interim data from the ALYFTREKÂ (vanzacaftor/tezacaftor/deutivacaftor) 2 to
3 weeks ago defenseworld.net
Head-To-Head Contrast: IMAX (NYSE:IMAX) versus iHuman (NYSE:IH)
iHuman (NYSE: IH - Get Free Report) and IMAX (NYSE: IMAX - Get Free Report) are both communication services companies, but which is the superior stock? We will contrast the two businesses based on…
-
1 month ago benzinga.com
iHuman Q2 Adj. EPS $(0.05) Down From $0.08 YoY, Sales $25.553M Down From $27.942M YoY
iHuman (NYSE:IH) reported quarterly losses of $(0.05) per share. This is a 162.5 percent decrease over earnings of $0.08 per share from the same period last year. The company reported $25.553 million…
1 month ago prnewswire.com
iHuman Inc. Announces Second Quarter 2026 Unaudited Financial Results
BEIJING, Sept. 29, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered knowledge and personal growth products, today announced its unaudited…
1 month ago gurufocus.com
New England Journal of Medicine Publishes Data from Phase 3 Studies Demonstrating Oveporexton (ORZEYFUL) Improved the Full Range of Narcolepsy Type 1 Symptoms and Quality of Life
Takeda (TSE:4502/NYSE: TAK) announced that the [url="]New England Journal of Medicine[/url] published results from two Phase 3 studies evaluating oveporexton (OR
2 months ago gurufocus.com
ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
Takeda ([url="]TOKYO:4502/NYSE: TAK[/url]) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) f
-
4 months ago benzinga.com
iHuman Q1 Adj. EPS $0.01 Down From $0.07 YoY, Sales $26.456M Down From $28.999M YoY
iHuman (NYSE:IH) reported quarterly earnings of $0.01 per share. This is a 85.71 percent decrease over earnings of $0.07 per share from the same period last year. The company reported $26.456 million…
4 months ago prnewswire.com
iHuman Inc. Announces First Quarter 2026 Unaudited Financial Results
BEIJING, June 29, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered knowledge and personal growth products, today announced its unaudited…
4 months ago prnewswire.com
Jazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav® (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Narcolepsy and Idiopathic Hypersomnia
New late-breaking data presentations underscore Jazz's significant progress in advancing holistic understanding of narcolepsy and idiopathic hypersomnia, including novel real-world evidence of…
5 months ago gurufocus.com
iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo
iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo PR Newswire
5 months ago prnewswire.com
iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo
BEIJING, May 31, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it has…
6 months ago prnewswire.com
iHuman Inc. Files 2025 Annual Report on Form 20-F
BEIJING, April 24, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it…
7 months ago benzinga.com
Earnings Scheduled For March 31, 2026
Earnings Scheduled For March 31, 2026
-
7 months ago benzinga.com
iHuman Q4 Adj. EPS $0.04 Down From $0.07 YoY, Sales $27.300M Down From $31.878M YoY
iHuman (NYSE:IH) reported quarterly earnings of $0.04 per share. This is a 42.86 percent decrease over earnings of $0.07 per share from the same period last year. The company reported $27.300 million…
7 months ago prnewswire.com
iHuman Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results
BEIJING, March 31, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its…
7 months ago benzinga.com
12 Communication Services Stocks Moving In Tuesday's Pre-Market Session
12 Communication Services Stocks Moving In Tuesday's Pre-Market Session
9 months ago defenseworld.net
iHuman Inc. Sponsored ADR (NYSE:IH) Sees Large Increase in Short Interest
iHuman Inc. Sponsored ADR (NYSE: IH - Get Free Report) was the target of a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 3,198…
-
10 months ago benzinga.com
Earnings Scheduled For December 29, 2025
Earnings Scheduled For December 29, 2025
-
10 months ago benzinga.com
iHuman Q3 Adj. EPS $0.06 Down From $0.07 YoY, Sales $28.900M Down From $34.115M YoY
iHuman (NYSE:IH) reported quarterly earnings of $0.06 per share. This is a 14.29 percent decrease over earnings of $0.07 per share from the same period last year. The company reported $28.900 million…
10 months ago prnewswire.com
iHuman Inc. Announces Third Quarter 2025 Unaudited Financial Results
BEIJING , Dec. 29, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its…
11 months ago seekingalpha.com
iHuman: Undervalued With Geographical Expansion Upside
iHuman (IH) offers educational apps and devices, trading at a deep discount to global peers and below its cash value, signaling undervaluation. IH is expanding internationally, notably in the US…
11 months ago newsfilecorp.com
iHuman to Present at Noble Capital Markets' 21st Annual Emerging Growth Equity Conference
Beijing, China--(Newsfile Corp. - November 24, 2025) - iHuman Inc. (NYSE: IH), a leading provider of tech-powered, intellectual development products in China, today announced that its Investor…
-
1 year ago benzinga.com
12 Communication Services Stocks Moving In Wednesday's After-Market Session
12 Communication Services Stocks Moving In Wednesday's After-Market Session
1 year ago benzinga.com
iHuman's International Push Boosted By Cricket Media Tie-up
iHuman's International Push Boosted By Cricket Media Tie-up
-
1 year ago benzinga.com
iHuman Q2 Adj. EPS $0.08 Up From $0.06 YoY, Sales $27.942M Down From $29.600M YoY
iHuman (NYSE:IH) reported quarterly earnings of $0.08 per share. This is a 33.33 percent increase over earnings of $0.06 per share from the same period last year. The company reported $27.942 million…
1 year ago prnewswire.com
iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results
BEIJING , Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its…
1 year ago prnewswire.com
iHuman and Cricket Media Team Up to Launch Reading Stars
Reading Stars seamlessly merges Cricket's award-winning content with iHuman's cutting-edge technology, creating an entirely new way for children to engage with reading. BEIJING and MCLEAN, Va.
-
1 year ago benzinga.com
12 Communication Services Stocks Moving In Thursday's Pre-Market Session
12 Communication Services Stocks Moving In Thursday's Pre-Market Session
-
1 year ago benzinga.com
iHuman Reported Q1 2025 MAUs Of 26.5M Vs 26.4M YoY
iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the first…
1 year ago prnewswire.com
iHuman Inc. Announces First Quarter 2025 Unaudited Financial Results
BEIJING , June 26, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its…
1 year ago prnewswire.com
iHuman Inc. Files 2024 Annual Report on Form 20-F
BEIJING , April 28, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it…
-
1 year ago benzinga.com
iHuman Q4 Adj $0.07 Down From $0.09 YoY, Sales $31.88M Beat $30.74M Estimate
iHuman (NYSE:IH) reported quarterly earnings of $0.07 per share. This is a 22.22 percent decrease over earnings of $0.09 per share from the same period last year. The company reported quarterly sales…
-
1 year ago benzinga.com
12 Communication Services Stocks Moving In Wednesday's Intraday Session
12 Communication Services Stocks Moving In Wednesday's Intraday Session
-
1 year ago benzinga.com
12 Communication Services Stocks Moving In Thursday's Pre-Market Session
12 Communication Services Stocks Moving In Thursday's Pre-Market Session
-
1 year ago benzinga.com
Tesla, Toyota And 3 Stocks To Watch Heading Into Thursday
Tesla, Toyota And 3 Stocks To Watch Heading Into Thursday
-
1 year ago benzinga.com
iHuman's Q3 MAUs Rose 14.8% YoY To 29.12M
Average total MAUs for the quarter were 29.12 million, an increase of 14.8% year-over-year from 25.36 million in the same period last year, primarily due to the effective execution of our user…
-
1 year ago benzinga.com
iHuman Extends Share Buyback Program By Another 12 Months Through End of 2025
Given its confidence in the Company's business prospects, the board of directors (the "Board") has authorized an extension of the Company's existing share repurchase program, as authorized in…
-
2 years ago benzinga.com
12 Communication Services Stocks Moving In Monday's Intraday Session
12 Communication Services Stocks Moving In Monday's Intraday Session
2 years ago benzinga.com
iHuman Misses China Stock Rally As Investors Fret Over Stumbling Growth
Key Takeaways: iHuman’s revenue and profit both declined in the first quarter as it accelerated a global expansion plan to diversify beyond its softening home market in China The company’s gross…
-
2 years ago benzinga.com
Earnings Scheduled For February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
-
2 years ago benzinga.com
Overview Of Value Stocks In The Consumer Defensive Sector
Overview Of Value Stocks In The Consumer Defensive Sector
-
3 years ago benzinga.com
A Look Into Consumer Defensive Sector Value Stocks
A Look Into Consumer Defensive Sector Value Stocks
-
3 years ago benzinga.com
5 Value Stocks To Watch In The Consumer Defensive Sector
5 Value Stocks To Watch In The Consumer Defensive Sector
-
3 years ago benzinga.com
5 Value Stocks In The Consumer Defensive Sector
5 Value Stocks In The Consumer Defensive Sector
-
3 years ago benzinga.com
12 Communication Services Stocks Moving In Monday's Intraday Session
12 Communication Services Stocks Moving In Monday's Intraday Session
-
3 years ago benzinga.com
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
-
4 years ago benzinga.com
Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday
Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) climbed 62.4% to close at $0.39. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation.
-
4 years ago benzinga.com
Why Vaxcyte Shares Are Trading Sharply Higher? Here Are 63 Stocks Moving In Monday's Mid-Day Session
Gainers Vaxcyte, Inc. (NASDAQ: PCVX) shares jumped 65% to $33.96 after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety,…
-
4 years ago benzinga.com
96 Biggest Movers From Yesterday
Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares surged 94.7% to close at $5.88 on Monday after the company announced it would be acquired for $6 per share.